Table 5.
Cohort comparison of patients treated with repeat CRS/HIPEC versus chemotherapy alone
| Chemotherapy alone (n = 36) | Repeat CRS/HIPEC (n = 50) | p value | |
|---|---|---|---|
| Age (years) (median, IQR) | 58 (52–62) | 53 (33–61) | 0.02 |
| Female gender (n, %) | 22 (61%) | 38 (63%) | 0.16 |
| Grade (n, %) | |||
| Well differentiated | 9 (21%) | 33 (66%) | < 0.001 |
| Moderately differentiated | 12 (33%) | 12 (24%) | |
| Poorly differentiated | 15 (42%) | 5 (10%) | |
Bold indicates statistically significant finding